First-in-Class Humanized Anti-DKK2 for Colorectal Cancer
Strong association of clinical biomarker - elevated DKK2 correlates with poor CRC prognosis. First-in-class therapeutic for colorectal cancer, targeting MSS CRC with multiple novel mechanisms of action and low risk for side effects. Complements current treatments like bevacizumab and shows efficacy
2 views • 11 slides
Performance Management Process Overview
This collection of documents provides a detailed overview of the performance management process, including key areas such as KRAs, objectives, performance indicators, and competencies. It guides the reader through the steps of completing forms, setting goals, monitoring and evaluating performance, a
2 views • 8 slides